Navco Pharmaceuticals Inc (NAV.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in thousands)
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Cash Flows From Operating Activities | ||||
| Other Working Capital | 29 | 0 | 10 | -15 |
| Other Operating Activity | -13 | -6 | -78 | -17 |
| Operating Cash Flow | $16 | $-6 | $-68 | $-32 |
| Cash Flows From Investing Activities | ||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | ||||
| Other Financing Activity | -52 | 0 | 250 | 73 |
| Financing Cash Flow | $-52 | $0 | $250 | $73 |
| Beginning Cash Position | 239 | 245 | 63 | 23 |
| End Cash Position | 204 | 239 | 245 | 63 |
| Net Cash Flow | $-35 | $-6 | $182 | $40 |
| Free Cash Flow | ||||
| Operating Cash Flow | 16 | -6 | -68 | -32 |
| Free Cash Flow | 16 | -6 | -68 | -32 |